Get started
Author

Li-Feng Hsu

Pharmacokinetics of vancomycin in adults receiving extracorporeal membrane oxygenation
2015 · Chien-Chih Wu, Li-Jiuan Shen, et al. · Journal of the Formosan Medical Association · 52
PDF
Analysis of Pharmacokinetic and Pharmacodynamic Parameters in EU- Versus US-Licensed Reference Biological Products: Are In Vivo Bridging Studies Justified for Biosimilar Development?
2019 · Chien-Lung Tu, Yi-Lin Wang, et al. · BioDrugs · 16
Model-based simulation to support the extended dosing regimens of atezolizumab
2020 · Chen-Hsi Chou, Li-Feng Hsu · European Journal of Clinical Pharmacology · 13
The bioequivalence study design recommendations for immediate-release solid oral dosage forms in the international pharmaceutical regulators programme participating regulators and organisations: differences and commonalities
2024 · Eduardo Agostinho Freitas Fernandes, Joy van Oudtshoorn, et al. · Journal of Pharmacy & Pharmaceutical Sciences · 12
PDF
Investigation of the Discriminatory Ability of Pharmacokinetic Metrics for the Bioequivalence Assessment of PEGylated Liposomal Doxorubicin
2018 · Li-feng Hsu · Pharmaceutical Research · 10
A statistical analysis to assess the most critical bioequivalence parameters for generic liposomal products
2014 · Li-feng Hsu, Jin-ding Huang · International Journal of Clinical Pharmacology and Therapeutics · 8
A Survey of the Regulatory Requirements for the Waiver of In Vivo Bioequivalence Studies of Generic Products in Certain Dosage Forms by Participating Regulators and Organisations of the International Pharmaceutical Regulators Programme
2021 · Alfredo Garcia Arieta, Craig Simon, et al. · Journal of Pharmacy & Pharmaceutical Sciences · 7
PDF
The role of partial area under the curve and maximum concentrations in assessing the bioequivalence of long-acting injectable formulation of exenatide_A sensitivity analysis
2024 · Hong-Jaan Wang, Li-Feng Hsu · European Journal of Pharmaceutical Sciences · 6
Requirements for Additional Strength Biowaivers for Modified Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities
2021 · Matthias Shona Roost, Henrike Potthast, et al. · Journal of Pharmacy & Pharmaceutical Sciences · 5
PDF
Approval of modified-release products by FDA without clinical efficacy/safety studies: A retrospective survey from 2008 to 2017
2019 · Yi-Lin Wang, Yi-Ting Chang, et al. · Regulatory Toxicology and Pharmacology · 5
A Survey of Population Pharmacokinetic Reports Submitted to the USFDA: An Analysis of Common Issues in NDA and BLA from 2012 to 2021
2022 · Li-Feng Hsu · Clinical Pharmacokinetics · 4
Investigation of the discriminatory ability of analytes for the bioequivalence assessment of ezetimibe: Parent drug, metabolite, total form, and combination of parent drug and total form
2022 · Chien-Ming Hsieh, Li-Feng Hsu · European Journal of Pharmaceutical Sciences · 4
PDF
Evaluation of etanercept dose reduction in patients with rheumatoid arthritis using pharmacokinetic/pharmacodynamic modeling and simulation
2014 · Li-feng Hsu, Jin-ding Huang · International Journal of Clinical Pharmacology and Therapeutics · 4
Evaluating the Feasibility of Use of a Foreign Reference Product for Generic Drug Applications: A Retrospective Pilot Study
2017 · Yi-lin Wang, Li-feng Hsu · European Journal of Drug Metabolism and Pharmacokinetics · 3
The Role of Early Exposure Metrics (pAUC0-3h and Cmax,0-3h) in Assessing the Bioequivalence of Methylphenidate Extended-release Products_A Sensitivity Analysis
2025 · Li-Feng Hsu · The AAPS Journal · 2
A survey of regulatory recommendations for waivers of in vivo bioequivalence studies of generic products for certain dosage forms by participating regulators and organisations of the International Pharmaceutical Regulators Programme. Part 2
2025 · Alfredo García-Arieta, Andrew Tam, et al. · Journal of Pharmacy & Pharmaceutical Sciences · 1
PDF
Leveraging Model-Based Simulations to Optimize Extended Dosing of Leuprolide 6-Month Intramuscular Depot Formulation
2025 · Li-Feng Hsu · European Journal of Drug Metabolism and Pharmacokinetics · 1
Authors’ reply to letters to the editor “model-based simulation to support the extended dosing regimens of atezolizumab”
2020 · Chen-Hsi Chou, Li-Feng Hsu · European Journal of Clinical Pharmacology · 1
Ten-year Experience of the Evaluation of Ethnic Sensitivity Data
2011 · Chia-Ling Hsiao, Yeong-Liang Lin, et al. · Drug Information Journal · 1
Profiling Readers in Multiple-Text Reading: Affective Engagement, Metacognition, and Mediation Effects
2025 · Zheng-Hong Guan, Sunny S. J. Lin, et al. · IEEE International Conference on Advanced Learning Technologies (ICALT)
A Survey of the Criteria Used for the Selection of Alternative Comparator Products by Participating Regulators and Organizations of the International Pharmaceutical Regulators Programme
2022 · Andrew Tam, Alfredo Garcia-Arieta, et al. · Journal of Pharmacy & Pharmaceutical Sciences
PDF
Works count: 21
Citation count: 155
H-index: 7
I10-index: 5
Year
Topic
Type